Synerzys Novaceuticals Private Limited - Company Profile

It is a chemicals and materials private limited company based in Patancheru, Telangana, India, established in 2015.
2015 Patancheru, Telangana, India Active
Last Updated:
Access Report
About Synerzys Novaceuticals Private Limited

Synerzys Novaceuticals Private Limited, a active private limited company, was established on 20 May 2015 in Patancheru, Telangana, India. Engaging in industrial chemicals within the chemicals and materials sector, it holds CIN: U24100TG2015PTC098988. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Nazneen Hamid (Director), Kaushal Kirtikumar Shah (Director), Kandhagatla Rajnarayana (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.25, Gowthamnagar, Patancheru, Telangana, 502319.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TG2015PTC098988

  • Registration Number

    098988

  • Incorporation Date

    20 May 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Profit Growth **** -57.13%
  • Ebitda **** -18.43%
  • Net Worth -53.41%
  • Total Assets **** 20.83%
Company report

Synerzys Novaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Synerzys Novaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Synerzys Novaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Nazneen Hamid Director 20 May 2015 Current
Kaushal Kirtikumar Shah Director 20 May 2015 Current
Kandhagatla Rajnarayana Director 20 May 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Synerzys Novaceuticals.

Synerzys Novaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 57.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 53.41%.

Synerzys Novaceuticals revenue growth over time
Synerzys Novaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 20.83%
*******
*******
*******
*******
Profit or Loss
*******
 -57.13%
*******
*******
*******
*******
Net Worth
*******
 -53.41%
*******
*******
*******
*******
EBITDA
*******
 -18.43%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Synerzys Novaceuticals?

In 2021, Synerzys Novaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Synerzys Novaceuticals?

Unlock and access historical data on people associated with Synerzys Novaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Synerzys Novaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synerzys Novaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Synerzys Novaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Synerzys Novaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Synerzys Novaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.

  • Director Appointment

    Nazneen Hamid was appointed as a Director was appointed as a Director on 20 May 2015 & has been associated with this company since 10 years 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Kaushal Kirtikumar Shah was appointed as a Director was appointed as a Director on 20 May 2015 & has been associated with this company since 10 years 9 months . was documented.

  • Director Appointment

    Kandhagatla Rajnarayana was appointed as a Director was appointed as a Director on 20 May 2015 & has been associated with this company since 10 years 9 months . was recorded as a recent event.

  • Company Incorporation

    Synerzys Novaceuticals Private Limited was registered on 20 May 2015 with Roc Hyderabad & aged 10 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Synerzys Novaceuticals Private Limited?

The CIN of Synerzys Novaceuticals Private Limited is U24100TG2015PTC098988.

Where is Synerzys Novaceuticals Private Limited headquartered?

Synerzys Novaceuticals Private Limited is headquartered at Plot No.25, Gowthamnagar, Patancheru, Telangana, 502319.

When was Synerzys Novaceuticals Private Limited incorporated?

Synerzys Novaceuticals Private Limited was incorporated on 20 May 2015.

Who are the current directors of Synerzys Novaceuticals Private Limited?

The current directors of Synerzys Novaceuticals Private Limited are

What is the primary industry of Synerzys Novaceuticals Private Limited?

The primary industry of Synerzys Novaceuticals Private Limited is Chemicals And Materials.

Is Synerzys Novaceuticals Private Limited a listed company?

Synerzys Novaceuticals Private Limited is unlisted.

What is the capital structure of Synerzys Novaceuticals Private Limited?

The authorized capital of Synerzys Novaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Synerzys Novaceuticals Private Limited?

The compliance status of Synerzys Novaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available